首页> 外文OA文献 >A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs

【2h】

A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs

机译：一种新的抗CD22蒽环类抗体 - 药物缀合物（ADC），克服了基于Auristatin的ADC的抗性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shang-Fan Yu; Bing Zheng; MaryAnn Go; Jeff Lau; Susan Spencer; Helga Raab; Robert Soriano; Suchit Jhunjhunwala; Robert Cohen; Michele Caruso; Paul Polakis; John Flygare; Andrew G. Polson;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs [J] . Yu Shang-Fan, Zheng Bing, Go MaryAnn, Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第14期

机译：新型抗CD22蒽环类抗体药物偶联物（ADC）克服了对基于Auristatin的ADC的耐药性
2. Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs [J] . Andreev Julian, Thambi Nithya, Bay Andres E. Perez, Molecular cancer therapeutics . 2017,第4期

机译：双特异性抗体和抗体 - 药物缀合物（ADCs）桥接HER2和催乳素受体提高了HER2 ADC的疗效
3. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs [J] . Kallsten Malin, Hartmann Rafael, Artemenko Konstantin, The Analyst: The Analytical Journal of the Royal Society of Chemistry: A Monthly International Publication Dealing with All Branches of Analytical Chemistry . 2018,第22期

机译：抗体 - 药物缀合物（ADC）的定性分析：半胱氨酸连接ADC的分析技术的实验比较
4. LOCALIZING THE CONJUGATION SITES OF CYSTEINE-CONJUGATED ANTIBODY DRUG CONJUGATES BY IMPROVED LC-MS SUBUNIT ANALYSIS FOR ADC POSITIONAL ISOMER IDENTIFICATION [C] . Henry Shion, Robert Birdsall, Liuxi Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：通过改进的LC-MS亚基分析来定位半胱氨酸缀合的抗体药物缀合物的共轭位点，用于ADC位置异构体识别
5. Investigating the Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates, T Cells and Bispecific Antibodies [D] . Khot, Antari . 2020

机译：调查抗体 - 药物缀合物，T细胞和双特异性抗体的药代动力学和药效学
6. Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADC [O] . Isabel Figueroa, Doug Leipold, Steve Leong, 2018

机译：当在动物中评估更高剂量时抗体-药物偶联物（ADC）在人体内的非线性药代动力学预测受耐受性限制：使用抗CD33 ADC的案例研究
7. Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs [O] . Julian Andreev, Nithya Thambi, Andres E. Perez Bay, 2017

机译：双特异性抗体和抗体 - 药物缀合物（ADCS）桥接HER2和催乳素受体提高了HER2 ADC的疗效

A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs

著录项

引文网络

相似文献

相关主题

期刊订阅